This morning private-market powerhouse Andreessen Horowitz announced that it has closed $9 billion in new capital for its venture capital, growth-stage and biotech-focused vehicles.
The firm, better known by the moniker a16z, also raised a $2.2 billion crypto-focused fund last year.
These fundraises by the firm highlight the rising size of private-market investing vehicles that we tend to group under the venture capital banner, and the burgeoning capital base of a16z itself.
Looking back in time, the group’s last generation of funds — including its seventh venture fund worth $1.3 billion, its second growth fund worth $3.2 billion and its third bio-focused fund worth $750 million — were worth just a touch over half of its latest aggregate fundraise. So, it appears that a16z is not only reloading, it’s raising more capital than ever for its usual crop of focuses.
That the group is raising larger investment capital pools should not s …
